StockData
Encompass Health Corp logo

Encompass Health Corp (EHC) shareholders

EHCNYSEServices-HospitalsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3012% above fair value
$137.88−4.23 (-2.98%)

Close on Nov 17, 2026Market cap $13.60BP/E 22.5Yield 0.52%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
97.0%
96M of 99M shares
Institutional holders
597
66 new, 41 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 18 sales
Net sold $47.79M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.9,125,7799.10%13G (passive) amendmentDec 31, 2023
Vanguard Capital Management5,233,6225.26%13G (passive)Mar 31, 2026
T. Rowe Price Associates, Inc.5,056,2255.10%13G (passive)Jun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of EHCValueChange% of portfolio
BlackRock, Inc.10,484,38510.63%$1.06B−284,3280.02%
Price T Rowe Associates Inc /Md/5,055,8015.12%$511.04M+455,2520.05%
Vanguard Portfolio Management LLC4,924,6644.99%$497.79M−34,8810.02%
Vanguard Capital Management LLC4,475,8964.54%$452.42M+9,6590.01%
Wellington Management Group Llp3,278,7393.32%$331.41M−570,1160.06%
State Street Corp3,185,7983.23%$322.02M+40,8240.01%
Citadel Advisors LLC2,563,1042.60%$259.08M+2,051,2170.03%
Alliancebernstein L.P.2,471,7512.51%$239.09M−149,4940.08%
Fuller & Thaler Asset Management, Inc.2,460,6572.49%$248.72M+230,6780.68%
Two Sigma Investments, LP2,267,6682.30%$229.22M+45,5670.17%
Geode Capital Management, LLC1,890,7431.92%$191.16M−7,9240.01%
Dimensional Fund Advisors LP1,743,0281.77%$176.19M+68,2440.03%
Goldman Sachs Group Inc1,550,7971.57%$156.75M−254,9240.01%
Invesco Ltd.1,161,1081.18%$117.36M−2,224,9970.01%
Arrowstreet Capital, Limited Partnership1,156,9301.17%$116.94M−25,6440.05%
Norges Bank1,154,8641.17%$116.73MNew0.01%
William Blair Investment Management, LLC1,151,0851.17%$116.35M+347,9340.35%
Morgan Stanley1,146,8731.16%$115.93M+249,8910.01%
JPMorgan Chase & Co1,133,5611.15%$114.84M−97,9100.01%
Raymond James Financial Inc1,064,2331.08%$107.57M−2,7730.03%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202659796M97.0%66 / 225223 / 4111M12M
Q1 202658096M97.7%77 / 231197 / 8321M17M
Q4 2025594102M100.0%83 / 176257 / 7817M10M
Q3 202560495M96.4%55 / 239230 / 5010M10M
Q2 202560795M96.3%113 / 206219 / 378M10M
Q1 202553797M98.0%60 / 202194 / 607M6M
Q4 202454496M97.1%98 / 208163 / 3111M12M
Q3 202448398M99.0%50 / 171198 / 3918M9M
Q2 202447898M99.3%74 / 173166 / 297M9M
Q1 2024436100M100.0%60 / 155150 / 578M9M
Q4 2023435101M100.0%63 / 147155 / 3513M6M
Q3 202341394M95.1%57 / 132157 / 295M5M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

560 funds held EHC in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of EHCValue% of fundAs of
iShares Core S&P Mid-Cap ETF3,394,8613.44%$343.15M0.28%Jun 30, 2026
Vanguard Total Stock Market Index Fund3,150,8443.19%$318.49M0.01%Jun 30, 2026
Fullerthaler Behavioral Small Cap Equity2,347,5462.38%$237.29M1.87%Jun 30, 2026
Vanguard Small-Cap Index Fund2,275,8922.31%$230.05M0.12%Jun 30, 2026
Vanguard Small-Cap Value Index Fund1,441,1391.46%$145.67M0.21%Jun 30, 2026
Vanguard Health Care Fund1,252,4981.27%$139.11M0.36%Jul 31, 2026
T. Rowe Price U.S. Large-Cap Core Fund, Inc.1,160,1031.18%$117.26M0.65%Jun 30, 2026
Vanguard Extended Market Index Fund1,137,4241.15%$114.97M0.12%Jun 30, 2026
Vanguard Explorer Fund1,034,9441.05%$114.95M0.52%Jul 31, 2026
SMALLCAP World Fund Inc848,0270.86%$85.72M0.09%Jun 30, 2026
iShares S&P Mid-Cap 400 Growth ETF593,4850.60%$59.99M0.53%Jun 30, 2026
Small Cap Growth Fund522,7260.53%$58.06M1.04%Jul 31, 2026
Fidelity Extended Market Index Fund518,1220.53%$54.84M0.13%May 31, 2026
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF502,1110.51%$50.75M0.28%Jun 30, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund483,1460.49%$48.84M0.50%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Mark J. TarrPresident & CEO, Director267,8140.27%Aug 11, 2026
John Patrick DarbyEVP, Gen Counsel & Secretary79,8990.08%Sep 1, 2026
Andrew L. PriceChief Accounting Officer69,4830.07%Sep 1, 2026
Douglas E. ColtharpEVP & Chief Financial Officer241,3680.24%Aug 11, 2026
Patrick William TuerEVP, Chief Operating Officer24,7550.03%May 12, 2026
Edmund FaySr. Vice Pres. and Treasurer89,3250.09%Mar 10, 2026
Elissa Joy CharbonneauChief Medical Officer17,6440.02%Mar 3, 2026
Edward M. Christie IIIDirector9,5770.01%Oct 19, 2026
Joan E. HermanDirector49,7240.05%Oct 19, 2026
Greg D. CarmichaelDirector20,3770.02%Oct 19, 2026
Leslye G. KatzDirector49,7240.05%Oct 19, 2026
Nancy M. SchlichtingDirector23,0100.02%Oct 19, 2026
Cain A. HayesDirector2,1000.00%Oct 19, 2026
Kevin J. O'ConnorDirector11,6000.01%Oct 19, 2026
Christopher R. ReidyDirector18,0810.02%Oct 19, 2026
Terrance WilliamsDirector16,8870.02%Oct 19, 2026
Patricia Anne MarylandDirector14,7640.01%Jul 16, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Edward M. Christie III
Director
Oct 19, 2026Award+221$126.63$27.99K9,577
Christopher R. Reidy
Director
Oct 19, 2026Award+284$126.89$36.04K18,081
Greg D. Carmichael
Director
Oct 15, 2026Award+28––20,377
Terrance Williams
Director
Oct 15, 2026Award+28––16,887
Nancy M. Schlichting
Director
Oct 15, 2026Award+38––23,010
Joan E. Herman
Director
Oct 15, 2026Award+81––49,724
Edward M. Christie III
Director
Oct 15, 2026Award+11––9,356
Christopher R. Reidy
Director
Oct 15, 2026Award+20––17,797
Cain A. Hayes
Director
Oct 15, 2026Award+4––2,100
Kevin J. O'Connor
Director
Oct 15, 2026Award+18––11,600
Leslye G. Katz
Director
Oct 15, 2026Award+81––49,724
Andrew L. Price
Chief Accounting Officer
Aug 31, 2026Sale−5,211$120.93$630.17K69,483
John Patrick Darby
EVP, Gen Counsel & Secretary
Aug 31, 2026Option exercise+4,858$35.06$170.32K79,899
John Patrick Darby
EVP, Gen Counsel & Secretary
Aug 31, 2026Sale−4,858$121.09$588.26K75,041
John Patrick Darby
EVP, Gen Counsel & Secretary
Aug 10, 2026Sale−8,906$125.95$1.12M75,041
Mark J. Tarr
President & CEO, Director
Aug 10, 2026Sale−1,579$126.06$199.05K267,814
Mark J. Tarr
President & CEO, Director
Aug 10, 2026Sale−171,569$125.46$21.53M269,393
Douglas E. Coltharp
EVP & Chief Financial Officer
Aug 10, 2026Sale−18,869$125.38$2.37M50,508
Edward M. Christie III
Director
Jul 16, 2026Award+248$112.43$27.88K9,345
Christopher R. Reidy
Director
Jul 16, 2026Award+319$112.40$35.86K17,777
Greg D. Carmichael
Director
Jul 15, 2026Award+29––20,349
Edward M. Christie III
Director
Jul 15, 2026Award+11––9,097
Terrance Williams
Director
Jul 15, 2026Award+29––16,859
Christopher R. Reidy
Director
Jul 15, 2026Award+21––17,458
Kevin J. O'Connor
Director
Jul 15, 2026Award+19––11,582
Joan E. Herman
Director
Jul 15, 2026Award+85––49,643
Cain A. Hayes
Director
Jul 15, 2026Award+4––2,096
Nancy M. Schlichting
Director
Jul 15, 2026Award+40––22,972
Leslye G. Katz
Director
Jul 15, 2026Award+85––49,643
Douglas E. Coltharp
EVP & Chief Financial Officer
May 15, 2026Option exercise+27,694$32.94$912.24K97,071
Douglas E. Coltharp
EVP & Chief Financial Officer
May 15, 2026Sale−27,693$106.83$2.96M69,378
Douglas E. Coltharp
EVP & Chief Financial Officer
May 15, 2026Sale−1$107.28$10769,377
Patrick William Tuer
EVP, Chief Operating Officer
May 11, 2026Sale−682$104.56$71.31K24,755
Nancy M. Schlichting
Director
May 7, 2026Award+1,634––22,932
Terrance Williams
Director
May 7, 2026Award+1,634––16,830
Greg D. Carmichael
Director
May 7, 2026Award+1,634––20,320
Edward M. Christie III
Director
May 7, 2026Award+1,634––9,086
Leslye G. Katz
Director
May 7, 2026Award+1,634––49,558
Christopher R. Reidy
Director
May 7, 2026Award+1,634––17,437
Kevin J. O'Connor
Director
May 7, 2026Award+1,634––11,563
Cain A. Hayes
Director
May 7, 2026Award+1,634––2,092
Joan E. Herman
Director
May 7, 2026Award+1,634––49,558
Edward M. Christie III
Director
Apr 16, 2026Award+261$106.17$27.71K7,452
Christopher R. Reidy
Director
Apr 16, 2026Award+334$106.48$35.56K15,803
Nancy M. Schlichting
Director
Apr 15, 2026Award+39––21,298
Joan E. Herman
Director
Apr 15, 2026Award+85––47,924
Leslye G. Katz
Director
Apr 15, 2026Award+85––47,924
Edward M. Christie III
Director
Apr 15, 2026Award+9––7,191
Christopher R. Reidy
Director
Apr 15, 2026Award+19––15,469
Terrance Williams
Director
Apr 15, 2026Award+27––15,196
Kevin J. O'Connor
Director
Apr 15, 2026Award+17––9,929
Greg D. Carmichael
Director
Apr 15, 2026Award+27––18,686
Cain A. Hayes
Director
Apr 15, 2026Award+1––458
Edmund Fay
Sr. Vice Pres. and Treasurer
Mar 9, 2026Sale−11,937$107.00$1.28M89,325
Edmund Fay
Sr. Vice Pres. and Treasurer
Mar 9, 2026Gift−3,000––86,325
Elissa Joy Charbonneau
Chief Medical Officer
Feb 28, 2026Tax withholding−369$107.88$39.81K17,644
Patrick William Tuer
EVP, Chief Operating Officer
Feb 28, 2026Tax withholding−545$107.88$58.79K25,437
Douglas E. Coltharp
EVP & Chief Financial Officer
Feb 28, 2026Tax withholding−776$107.88$83.71K69,377
John Patrick Darby
EVP, Gen Counsel & Secretary
Feb 28, 2026Tax withholding−416$107.88$44.88K83,947
Andrew L. Price
Chief Accounting Officer
Feb 28, 2026Tax withholding−307$107.88$33.12K74,694

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.70%
4M shares short
Days to cover
2.7
At 1M shares a day
Change since last report
+9.1%
From 3M shares
Short volume, 20 days
50.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Encompass Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 44,643 shares on Oct 7, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
John Patrick Darby
Officer
Aug 31, 20264,858$588.26KAug 31, 2026Stock Option Exercise
Douglas E. Coltharp
Officer
Aug 10, 202618,869$2.37MAug 10, 2026RSA Vesting
John Patrick Darby
Officer
Aug 10, 20268,906$1.12MAug 10, 2026RSU Vesting
Mark J. Tarr
Officer
Aug 10, 2026173,148$21.72MAug 10, 2026Equity Plan
Douglas E. Coltharp
Officer
May 15, 202627,694$2.96MMay 15, 2026Stock Option Exercise
Patrick William Tuer
Officer
May 11, 2026682$71.31KMay 11, 2026RSA Vesting
Mark J. Tarr
Officer
Feb 11, 2026150,000$16.74MFeb 11, 2026RSA Vesting
Patrick William Tuer
Officer
Feb 10, 20262,804$301.76KFeb 10, 2026RSU Vesting
Patrick William Tuer
Officer
Aug 27, 20251,020$126.06KAug 27, 2025RSU Vesting
Mark J. Tarr
Officer
May 20, 2025118,384$14.38MMay 20, 2025Stock Option Exercise
Douglas E. Coltharp
Officer
Apr 29, 202543,575$5.02MApr 29, 2025Stock Option Exercise
John Patrick Darby
Officer
Apr 29, 202514,858$1.71MApr 29, 2025Stock Option Exercise
Douglas E. Coltharp
Officer
Aug 13, 202412,260$1.06MAug 13, 2024Stock Option Exercise
John Chidsey
Officer
May 22, 202429,500$2.52MMay 22, 2024Vesting of restricted stock unit award
John Patrick Darby
Officer
May 6, 202414,543$1.22MMay 6, 2024stock option exercise

Congress trades

4 trades in Encompass Health reported by 1 member of the House

MemberTypeTradedAmountFiled
Lisa McClain
MI09 · spouse
SoldOct 31, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
SoldOct 30, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
BoughtOct 30, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
BoughtJul 22, 2025$1K–15KAug 13, 2025

See a number that looks wrong?